JACOBS LEVY EQUITY MANAGEMENT, INC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 37 filers reported holding UNUM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$48,000
-59.0%
32,994
-26.3%
0.00%
-50.0%
Q2 2019$117,000
-75.6%
44,774
-59.0%
0.00%
-71.4%
Q1 2019$479,000
+121.8%
109,075
+121.7%
0.01%
+75.0%
Q4 2018$216,00049,1970.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$37,347,00028.23%
Novo Holdings A/S 665,181$31,669,0003.97%
New Leaf Venture Partners, L.L.C. 550,000$6,111,0003.30%
SECTORAL ASSET MANAGEMENT INC 1,081,545$12,016,0001.32%
SABBY MANAGEMENT, LLC 1,106,445$12,292,0000.73%
Monashee Investment Management LLC 175,000$1,944,0000.54%
DC Investments Management, LLC 35,524$395,0000.26%
Athanor Capital, LP 22,300$248,0000.12%
PLATINUM INVESTMENT MANAGEMENT LTD 225,000$2,499,0000.07%
Schonfeld Strategic Advisors LLC 73,000$811,0000.06%
View complete list of UNUM THERAPEUTICS INC shareholders